| Autor: |
Szabó, György, Éliás, Olivér, Erdélyi, Péter, Potor, Attila, Túrós, György I., Károlyi, Benedek I., Varró, Gábor, Vaskó, Ágnes Gy., Bata, Imre, Kapus, Gábor L., Dohányos, Zoltán, Bobok, Amrita Á., Fodor, László, Thán, Márta, Vastag, Mónika, Komlódi, Zsolt, Soukupné Kedves, Rita É., Makó, Éva, Süveges, Brigitta, Greiner, István |
| Zdroj: |
Journal of Medicinal Chemistry; June 2022, Vol. 65 Issue: 11 p7876-7895, 20p |
| Abstrakt: |
The discovery and characterization of novel naphthyridine derivatives with selective α5-GABAAR negative allosteric modulator (NAM) activity are disclosed. Utilizing a scaffold-hopping strategy, fused [6 + 6] bicyclic scaffolds were designed and synthesized. Among these, 1,6-naphthyridinones were identified as potent and selective α5-GABAAR NAMs with metabolic stability, cardiac safety, and beneficial intellectual property (IP) issues. Relocation of the oxo acceptor function and subsequent modulation of the physicochemical properties resulted in novel 1,6-naphthyridines with improved profile, combining good potency, selectivity, ADME, and safety properties. Besides this, compound 20, having the most balanced profile, provided in vivo proof of concept (POC) for the new scaffold in two animal models of cognitive impairment associated with schizophrenia (CIAS). |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
